2021
CLO21-025: Benefit of Deep Inspiratory Breath Hold for Right Breast Cancer When Regional Lymph Nodes Are Irradiated
Peters G, Gao S, Knowlton C, Zhang A, Evans S, Higgins S, Wilson L, Saltmarsh N, Picone M, Moran M. CLO21-025: Benefit of Deep Inspiratory Breath Hold for Right Breast Cancer When Regional Lymph Nodes Are Irradiated. Journal Of The National Comprehensive Cancer Network 2021, 19: clo21-025. DOI: 10.6004/jnccn.2020.7707.Peer-Reviewed Original Research
2019
Planned Interim Analysis Results from a Prospective Multicenter Single-Arm Cohort Study of Patients Receiving Endocrine Therapy but Not Radiotherapy after Breast-Conserving Surgery for Early-Stage Breast Cancer with Favorable Biologic Features
Jagsi R, Griffith K, Harris E, Wright J, Recht A, Taghian A, Lee L, Moran M, Thomas T, Johnstone C, Rahimi A, Freedman G, Muzaffar M, Haffty B, Horst K, Powell S, Sharp J, Sabel M, Schott A, El-Tamer M. Planned Interim Analysis Results from a Prospective Multicenter Single-Arm Cohort Study of Patients Receiving Endocrine Therapy but Not Radiotherapy after Breast-Conserving Surgery for Early-Stage Breast Cancer with Favorable Biologic Features. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: s7-s8. DOI: 10.1016/j.ijrobp.2019.06.392.Peer-Reviewed Original ResearchPV-0045 Is proton therapy a "pro" for breast cancer? A comparison of proton vs. non-proton RT using the NCDB
Chowdhary M, Lee A, Gao S, Barry P, Diaz R, Bagadiya N, Park H, Yu J, Wilson L, Moran M, Higgins S, Knowlton C, Patel K. PV-0045 Is proton therapy a "pro" for breast cancer? A comparison of proton vs. non-proton RT using the NCDB. Radiotherapy And Oncology 2019, 133: s15. DOI: 10.1016/s0167-8140(19)30465-7.Peer-Reviewed Original Research
2017
Radiation Oncology Considerations in the Management of Mutation Carriers with Breast Cancer
Moran M. Radiation Oncology Considerations in the Management of Mutation Carriers with Breast Cancer. 2017, 151-170. DOI: 10.1007/978-3-319-59198-8_9.Peer-Reviewed Original ResearchBreast cancerMutation carriersRadiation therapyLocal-regional managementPost-mastectomy settingBreast conservation therapyBRCA mutation carriersTreatment management decisionsBRCA mutation statusHereditary breast cancerBreast conservationTNBC patientsConservation therapyBRCA carriersFamily historyMutation statusRadiation therapy deliveryTreatment conceptGenetic testingBRCA genesCancerTherapyStrong associationTherapy deliveryPresent guidelines
2016
Recent Updates in the Management of Triple Negative Breast Cancer
Sanft T, Moran M. Recent Updates in the Management of Triple Negative Breast Cancer. TouchREVIEWS In Oncology & Haematology 2016, 12: 36. DOI: 10.17925/ohr.2016.12.01.36.Peer-Reviewed Original ResearchTriple-negative breast cancerNegative breast cancerBreast cancerLocoregional treatment optionsComplete pathologic responseNeoadjuvant chemotherapyPathologic responseResidual diseaseTreatment optionsAggressive subtypeNew agentsCancerDruggable targetsDisease biologyRecent updatesFurther researchChemotherapyPatientsTherapySubtypesDisease
2014
Significance of Phospho(Ser73)-K8 Expression in Women With Breast Cancer of Triple Negative Phenotype
Garg R, Housri N, Kongara S, Wu H, Schiff D, Moran M, Karantza V, Haffty B. Significance of Phospho(Ser73)-K8 Expression in Women With Breast Cancer of Triple Negative Phenotype. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s69-s70. DOI: 10.1016/j.ijrobp.2014.05.230.Peer-Reviewed Original ResearchThe Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer: Perspectives for Pathologists
Schnitt SJ, Moran MS, Houssami N, Morrow M. The Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer: Perspectives for Pathologists. Archives Of Pathology & Laboratory Medicine 2014, 139: 575-7. PMID: 25153620, DOI: 10.5858/arpa.2014-0384-ed.Peer-Reviewed Original Research
2012
Association Between Tumor Molecular Subtype and Disease Presentation in Patients With Early-stage Breast Cancer
Jones T, Neboori H, Haffty B, Wu H, Yang Q, Moran M. Association Between Tumor Molecular Subtype and Disease Presentation in Patients With Early-stage Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s141. DOI: 10.1016/j.ijrobp.2012.07.164.Peer-Reviewed Original Research
2011
The Prognostic Value of MDM2, MDM4 (MDMX), and p53 in Early Stage Breast Cancer Treated with Breast Conserving Surgery and Radiotherapy
Neboori H, Wu H, Schiff D, Goyal S, Moran M, Yang J, Hirshfield K, Haffty B. The Prognostic Value of MDM2, MDM4 (MDMX), and p53 in Early Stage Breast Cancer Treated with Breast Conserving Surgery and Radiotherapy. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s62-s63. DOI: 10.1016/j.ijrobp.2011.06.126.Peer-Reviewed Original Research
2010
Breast Conservation Therapy and BRCA Status Do Not Predict for Poor Outcomes in Young Women with Early-stage Breast Cancer
Patel A, Goyal S, Moran M, Choi D, Haffty B. Breast Conservation Therapy and BRCA Status Do Not Predict for Poor Outcomes in Young Women with Early-stage Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s213. DOI: 10.1016/j.ijrobp.2010.07.513.Peer-Reviewed Original Research7N Local therapy options in BRCA1/2 carriers with operable breast cancer: the importance of adjuvant chemotherapy
Pierce L, Phillips K, Griffith K, Buys S, Gaffney D, Moran M, Haffty B, Ben-David M, Garber J, Merajver S, Balmaña J, Meirovitz A, Domchek S. 7N Local therapy options in BRCA1/2 carriers with operable breast cancer: the importance of adjuvant chemotherapy. European Journal Of Cancer Supplements 2010, 8: 55. DOI: 10.1016/s1359-6349(10)70034-3.Peer-Reviewed Original Research
2009
Identification of genes associated with multiple cancers via integrative analysis
Ma S, Huang J, Moran MS. Identification of genes associated with multiple cancers via integrative analysis. BMC Genomics 2009, 10: 535. PMID: 19919702, PMCID: PMC2785840, DOI: 10.1186/1471-2164-10-535.Peer-Reviewed Original ResearchConceptsTypes of cancerMultiple cancersMeta-AnalysisDifferent cancersCommon susceptibility genesMicroarray studiesProgression of cancerLeave-one-out cross-validation approachCancer-associated genesTreatment selectionPrognosis predictionCancerCancer developmentSusceptibility genesSpecific typesGene profiling techniquesIdentification of genesIntegrative analysis approachGenesRadiation Techniques and Toxicities for Locally Advanced Breast Cancer
Moran MS, Haffty BG. Radiation Techniques and Toxicities for Locally Advanced Breast Cancer. Seminars In Radiation Oncology 2009, 19: 244-255. PMID: 19732689, DOI: 10.1016/j.semradonc.2009.05.007.Peer-Reviewed Original ResearchBreast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups
Haffty BG, Choi DH, Goyal S, Silber A, Ranieri K, Matloff E, Lee MH, Nissenblatt M, Toppmeyer D, Moran MS. Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Annals Of Oncology 2009, 20: 1653-1659. PMID: 19491284, DOI: 10.1093/annonc/mdp051.Peer-Reviewed Original ResearchConceptsBreast cancerSecondary malignanciesAge of onsetFamily historyBRCA1/2 mutationsYoung womenBRCA1/2 mutation statusBreast cancer diagnosisEligible womenSecond cancersInitial diagnosisBRCA1/2 statusMutation statusBRCA1/2 genesYounger ageKorean womenCancerMalignancyUncertain significanceCancer diagnosisCaucasiansWomenDiverse racial groupsFrequent mutationsSignificant differences
2007
Differences between African American (AA) and Caucasian (C) Patients Treated With Conservative Surgery and Radiation Therapy (CS+RT) for Early Stage Breast Cancer
Moran M, Harris L, Haffty B. Differences between African American (AA) and Caucasian (C) Patients Treated With Conservative Surgery and Radiation Therapy (CS+RT) for Early Stage Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s4-s5. DOI: 10.1016/j.ijrobp.2007.07.010.Peer-Reviewed Original Research